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myb7 mRNA is present in rice in spliced and unspliced
forms, splicing being enhanced by anoxia. The protein
(Mybleu) encoded by the unspliced mRNA is composed
of an incomplete Myb domain followed by a leucine zip-
per; however, it lacks canonical sequences for DNA
binding, transcriptional activation, and nuclear local-
ization. We show here that in transiently transformed
tobacco protoplasts, Mybleu is able to enhance the tran-
scriptional activity of the maize leucine zipper Opaque2
on its target b32 promoter. The Mybleu transactivation
effect is strictly dependent on the presence of Opaque2
and is driven by Mybleu-Opaque2 heterodimers. Mybleu
is located in the nucleus, both in rice and in transformed
tobacco protoplasts. In rice, the protein is expressed in
regions corresponding to undifferentiated cells of roots
and coleoptiles. Therefore, myb7 mRNA encodes, de-
pending on its splicing, two transcription factors be-
longing to separate classes. One of them, Mybleu, has
novel structural characteristics, suggesting the exist-
ence of new mechanisms acting in the activation of
transcription.
Mybs are a family of transcription factors widely represented
in viruses, insects, mammals, and plants. The common feature
of Myb factors is the presence of a conserved domain consisting
of imperfect repeats of 50–53 amino acids, called “tryptophan
clusters” because of the highly conserved tryptophan residues
involved in stabilizing the structure of the DNA binding do-
main (1). In plants, myb genes are present as large families
(6–100 members) involved in the control of a wide range of
biochemical pathways (2–6), including responses to biotic and
abiotic stresses (7–13).
Screening a cDNA library from anaerobically grown rice
coleoptiles, we isolated myb7, a cDNA derived from a Myb-
encoding unspliced mRNA (8). Some features of myb7 sequence
indicate that it may be post-transcriptionally regulated; in
particular, two unspliced introns are present in positions that
are conserved with respect to other plant myb genes. Both
spliced and unspliced myb7 mRNAs are present in vivo (7).
In aerobically grown rice roots, we observed a higher propor-
tion of unspliced myb7 RNA, with respect to the spliced form.
The spliced form is instead predominant in rice roots during
anoxia, a stress situation that generally inhibits splicing (14).
These data suggest that post-transcriptional regulation con-
trols the ratio between myb7 unspliced and spliced forms (7).
This hypothesis is supported by the observation that the 59
region of the first intron can direct the synthesis of an in-frame
leucine zipper, a functional domain present in several tran-
scription factors (15–18).
The putative polypeptide encoded by the unspliced myb7
mRNA consists of an incomplete Myb domain followed by the
leucine zipper: we therefore named it Mybleu. Mybleu does not
have the characteristics of a functional transcription factor.
Indeed, it should be unable to bind DNA because of the pres-
ence of an incomplete Myb repeat. Moreover, neither a putative
transcriptional activator region nor a consensus for nuclear
targeting can be identified in Mybleu. The synthesis of the
putative Mybleu polypeptide may, however, provide the cell
with a mechanism able to regulate the dimerization and hence
activity of other transcription factors.
Our main goal in this study was to determine whether My-
bleu is able to interact with a leucine zipper protein and mod-
ulate its activity. To this purpose, we have transiently ex-
pressed Mybleu in tobacco protoplasts together with the maize
leucine zipper Opaque2 (O2)1.
Transient assays are used widely to provide functional infor-
mation on transcription factors (19 and references therein). O2
is a very well characterized plant leucine zipper transcription
factor that transactivates the b32 promoter both in maize en-
dosperm and in transient assay in tobacco protoplasts (18, 20,
21). Moreover, recent data suggest that a bZIP protein func-
tionally similar to O2 may exist in rice (22).
We show that Mybleu does not inhibit, but instead enhances
the transactivation on the b32 promoter by O2. This effect
seems to be driven by heterodimers, which are quantitatively
formed between O2 and Mybleu. We also show that Mybleu is
located in the nucleus both in rice cells and in transformed
tobacco protoplasts.
Therefore, a heterodimer consisting of two natural leucine
zipper transcription factors, one complete and the other lacking
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the transcriptional and binding domains, is able to activate
transcription in plant cells. Mybleu presence in rice strongly
suggests that such a mechanism is a natural one.
EXPERIMENTAL PROCEDURES
Plant Material
Maintenance of in vitro shoot cultures of Nicotiana tabacum (cultivar
Petit-Havana, SRI) and preparation of apical segments from rice (cul-
tivar Arborio) roots and coleoptiles were described previously (23, 24).
Production of Anti-Mybleu Antiserum
The intronic KpnI-XbaI fragment, coding for the 33 COOH-terminal
amino acids of Mybleu, absent in the Myb protein encoded by the spliced
mRNA (7), was inserted into the pMAL-p2 expression vector cut with
EcoRI and XbaI (25). The maltose-binding protein-Mybleu fusion pro-
tein (molecular mass 44 kDa, as expected) was isolated following stand-
ard protocols (25). 4 mg was used to immunize New Zealand White
rabbits. Periplasmic and cytoplasmic extracts (25) of untransformed
and transformed Escherichia coli, before and after isopropyl-b-D-thio-
galactopyranoside induction, were subjected to Western blot as positive
and negative controls.
Plasmid Constructs
pCaMVCAT (4.2 kb), pCaMVNeo (4.4 kb), pCaGUS (5.3 kb),
pCaMV-O2 (4.7 kb) expressing, respectively, CAT, neomycin phospho-
transferase II, GUS, and O2 open reading frames, all under the consti-
tutive CaMV 35S promoter, and pB32GUSII (4.1 kb), expressing the
GUS open reading frame under the b32 promoter, have been described
previously (20, 23, 26, 27). The NheI-ScaI fragment of unspliced myb7
cDNA (8), which encodes Mybleu, was inserted between the SmaI and
ScaI sites of pCaGUS, to yield pCaMVMybleu (4.4 kb). Representation
of the plasmids used in this work is in Fig. 1A.
Transient Expression in Tobacco Protoplasts
Mesophyll protoplasts from tobacco leaves were isolated according to
Nagy and Maliga (28) and Potrykus and Shillito (29) and transformed
according to Bilang et al. (30). Protoplast viability was checked by the
fluorescein diacetate method (31). Protoplast extracts were used for
GUS and CAT activity determinations. Protein concentration was de-
termined by the method of Lowry as modified by Peterson (32). Results
are the means of at least four transformation experiments.
Determination of GUS and CAT Activities
GUS activity was determined according to Jefferson (33). CAT activ-
ity was assayed as described by Sambrook et al. (34). Protoplast trans-
formations with GUS-expressing constructs always included an inter-
nal reference marker (10 mg of pCaMVCAT plasmid), and the level of
GUS expression was referred as a ratio between the coexpressed GUS
and CAT activities. Transactivation of the b32 promoter was expressed
as fold stimulation with respect to the GUS expression driven by the
pB32GUSII plasmid alone. Because pCaMV-O2 (20) and pCaMVMy-
bleu are similar in size (4.7 and 4.4 kb, respectively), we considered
equal amounts of them as equimolar.
Isolation of Nuclear Fractions and Immunological Analysis
Cytoplasmic and nuclei-enriched subcellular fractions from frozen
root and coleoptile segments and from transformed protoplasts were
isolated as described (24) and then loaded on discontinuous Percoll
gradient to obtain a pure nuclear fraction (35). The purity of the nuclear
preparations was assayed by UV fluorescence microscopy after DAPI (1
mg/ml) staining. Nuclear or cytoplasmic proteins from rice roots and
coleoptiles and nuclear proteins from transformed protoplasts (800 mg)
were immunoprecipitated with anti-O2 or anti-Mybleu antiserum, as
described by D’Amico et al. (36). Total nuclear or cytoplasmic extracts
and immunoprecipitated proteins were fractionated by SDS-PAGE (37)
and blotted onto nitrocellulose membrane (PROTRAN BA 85, 0.20 mm,
Schleicher & Schuell) (38). Immunodetection of total extracts was per-
formed by Western blot according to Harlow and Lane (39). The detec-
tion of immunoprecipitated proteins was performed using only the
primary rabbit antisera (anti-Mybleu and anti-O2), coupled to alkaline
phosphatase (40). Nuclear extracts from transformed tobacco proto-
plasts used to perform gel shift experiments were prepared as described
by Schmidt et al. (41).
Analysis of Mybleu and O2 Assembly by Sedimentation Velocity
Nuclear extracts (500 mg) of protoplasts transformed with plasmids
expressing O2, Mybleu, or both were loaded on a continuous 5–25%
(w/v) linear sucrose gradient (42). A mixture (50 mg each) of cytochrome
c (12 kDa), ovalbumin (43 kDa), bovine serum albumin (67 kDa), aldol-
ase (a 142-kDa trimer) and catalase (a 232-kDa tetramer) was used as
a marker for molecular mass separation along the gradient. Samples
were centrifuged at 39,000 rpm in a SW40 Ti rotor (Beckman, Fuller-
ton, CA) for 40 h at 4 °C. After centrifugation, gradients were collected
in 700-ml fractions. Density was measured with a refractometer. An
aliquot (350–700 ml) of each fraction was trichloroacetic acid precipi-
tated and analyzed by Western blot after 15% acrylamide SDS-PAGE
(37–39).
Electrophoretic Mobility Shift Assays
This assay was performed according to a described procedure (41)
with minor modifications. The following double strand oligonucleotides
were used (the O2 binding sites are indicated in bold).
O2—59-GGCATTCCACGTAGATAACC-39 corresponding to the O2
binding site on the zein promoter.
O2B—59-GGCCGCTCCACGTAGATAAGCTTCATTC-
CACGTAGATCTAG-39 containing two O2 binding sites of the zein
promoter (38).
2,3 B32—59-GGAGATGATGTGGAAAGTTAGTGGGAGATGATA-
TGGATGCC-39 corresponding to the B2 and B3 O2 binding sites of the
b32 promoter.
3 B32—59-GGACGAGATGATGTGGAACC-39 corresponding to the
B3 O2 binding site of the b32 promoter.
FIG. 1. Mybleu synergistic activity on O2-driven transactiva-
tion of the b32 promoter. Panel A, schematic representation of the
plasmids used in tobacco protoplast transformations. Dotted rectangles
represent promoters: 35S, CaMV 35S; B32, b32 promoter. Open rectan-
gles represent open reading frames. Functional domains: myb, partial
Myb domain; leucine-zip, leucine zipper; acidic, acidic domain; basic,
basic domain; black dots, nuclear localization signal. Hatched rectan-
gles represent Nos terminator. NEO, neomycin phosphotransferase II.
Panel B, tobacco protoplasts were transformed with pB32GUSII (B32),
pCaMV-O2 (O2), and pCaMVMybleu (Myb). The amounts of plasmids
used are indicated in mg/test. Bars represent the standard deviations of
four independent transformation events.
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5 B32—59-GGACGAGTTGACGTTGAACC-39corresponding to the
B5 O2 binding site of the b32 promoter (20).
Oligonucleotides were annealed and labeled as described by Ciceri et
al. (38). 10 mg of transformed protoplasts nuclear extract for each
sample were incubated 10 min at room temperature in binding buffer
(10 mM Hepes, pH 7.9, 1 mM EDTA, 2 mg/ml bovine serum albumin, 100
mg/ml salmon sperm DNA, 10% glycerol) containing KCl at three dif-
ferent concentrations (40, 70, 100 mM). The probe was then added to the
extracts and the reactions allowed for 20 min at room temperature.
Samples were then loaded onto a 4% polyacrylamide gel in 23 mM Tris
borate, 0.5 mM EDTA, pH 8. Gels were run at 4 °C, dried, and autora-
diographed. The presence and the relative amount of O2 and Mybleu in
the extracts were assayed by Western blot (data not shown).
Immunocytochemical Analysis
Immunocytochemical analysis on tobacco transformed protoplasts
was performed as reported (43). Phosphatase activity was detected by
4-nitro blue tetrazolium chloride (Sigma) in a 5-min reaction (40).
Nuclei were stained with the DNA-specific fluorochrome DAPI (2 mg/
ml). Nitrocellulose filters were examined and photographed under a
Zeiss Axioplan fluorescence microscope, using an excitation filter LP
400 to detect DAPI fluorescence.
For immunochemical assays on rice tissues, roots and coleoptiles
were spread on nitrocellulose filters by applying them with gentle
pressure. Tissue prints were then processed for immunodetection as
described above.
RESULTS
Mybleu Has a Synergistic Effect on O2-driven Transactiva-
tion—The presence of a leucine zipper domain and the absence
of both DNA binding and transactivation domains suggest that
Mybleu might act as a dominant repressor, according to the
results obtained with other incomplete transcription factors
(44–47). We therefore investigated the action of Mybleu on the
activity of O2, using as a target the b32 promoter. The in vivo
assays were performed in transiently transformed tobacco pro-
toplasts, using the plasmids shown in Fig. 1A. We first verified
whether cotransformations of protoplasts with several plas-
mids carrying the same strong promoter region (CaMV 35S)
influence the expression of the individual constructs. Increas-
ing amounts (10–60 mg/test) of pCaMVNeo did not affect the
expression of 10 mg of pCaMVCAT or pCaGUS (data not
shown). Therefore, we compared the GUS expression driven by
the b32 promoter in the presence of O2, Mybleu, or both.
Surprisingly, Mybleu did not inhibit O2 transactivation, but
had a stimulatory effect (Fig. 1B).
The fold stimulation of Mybleu on O2 activity was always
similar, within a wide range of amounts of plasmids expressed
(0.1–10 mg/test; Fig. 1B). The stimulation driven by 1 mg of O2
seems higher at lower concentrations of the b32 promoter be-
cause our unit of measure is the GUS activity driven by the b32
promoter in the absence of O2. This is, of course, markedly
higher at higher concentrations of the b32 promoter; for this
reason the transactivation efficiency (fold stimulation) of a
given amount of O2 seems lower at higher concentration of b32
promoter, unless the amount of the promoter is limiting.
A pCaMV-O2 dependent (0.1–10 mg range) linear enhance-
ment of the GUS expression was observed both when 1 mg and
10 mg of pB32GUSII were used (data not shown). These results
suggest that the effect of Mybleu on O2 activity does not de-
pend on its interaction with an unknown tobacco cellular factor
that may sequester O2. If a tobacco factor able to interact with
O2 and inhibit its activity existed, it would be saturable. In this
case, the Mybleu effect would be higher at lower O2, and
Mybleu concentrations and the O2-driven transactivation of
the b32 promoter would be less efficient at lower concentra-
tions of O2. The possibility of a direct activity of Mybleu on the
b32 promoter was also ruled out because in the absence of O2,
Mybleu did not stimulate the activity of the b32 promoter
(Fig. 1B).
Finally, as shown in Fig. 1B, the GUS activities induced by 8
mg of pCaMV-O2 or 4 mg of pCaMV-O2 and 4 mg of pCaMVMy-
bleu are similar and significantly higher than the activity
induced by 4 mg of pCaMV-O2.
Mybleu Interacts Directly with O2—The possible direct phys-
ical interaction between Mybleu and O2 was tested by immu-
noprecipitation experiments. Nuclear extracts of protoplasts
transformed with pCaMV-O2, pCaMVMybleu, or both plas-
mids (10 mg each) were immunoprecipitated with anti-O2 or
anti-Mybleu antiserum and analyzed by Western blot with a
mixture of both antisera. As shown in Fig. 2A, both antisera
(Ab O2 and MYB) immunoprecipitated specifically the corre-
spondent antigen in single transformants (O2 and MYB). The
specificity of immunoprecipitations was confirmed by the ab-
sence of immunoprecipitated proteins in pCaMV-O2 trans-
formed protoplasts by Mybleu antiserum and vice versa. There-
fore, the coimmunoprecipitation of both factors with any of the
two antisera in the double transformants (O2/MYB) indicates a
direct interaction. Immunoprecipitation appeared quantitative
for both proteins, irrespectively of the antiserum used, suggest-
ing a complete interaction between Mybleu and O2 (Fig. 2B,
lanes 3 and 6). Consistently, using anti-Mybleu antiserum, we
were unable to immunoprecipitate any protein from the super-
natant after immunoprecipitation with anti-O2 antiserum and
vice versa (Fig. 2B, lanes 2 and 4). We were finally unable to
detect O2 or Mybleu analyzing by Western blot the superna-
tants of the immunoprecipitations, indicating that the two
proteins were quantitatively available for immunoprecipitation
(data not shown).
Mybleu and Opaque2 Form Heterodimers—To determine the
assembly state of Mybleu and O2, nuclear extracts from to-
bacco protoplasts transformed with plasmids expressing O2,
Mybleu, or both (10 mg/each) were loaded onto preformed linear
sucrose gradients (5–25% w/v) and subjected to sedimentation
velocity centrifugation. A mixture of molecular mass markers
FIG. 2. Coimmunoprecipitation of Mybleu and O2. Panel A, nu-
clear proteins were extracted from tobacco protoplasts transformed
with pCaMV-O2, pCaMVMybleu, or both (O2, MYB, and O2/MYB, as
indicated at the top of the figure) and immunoprecipitated with anti-
serum anti-O2 (O2 lanes) or anti-Mybleu (Myb lanes). Panel B, nuclear
proteins were extracted from tobacco protoplasts cotransformed with
pCaMV-O2 and pCaMVMybleu and immunoprecipitated (1st Ab) with
antisera anti-O2 (O2) or anti-Mybleu (Myb) (lanes 3 and 6). Each
supernatant was again immunoprecipitated (2nd Ab) with either the
same antiserum (lanes 1 and 5) or with the other one (lanes 2 and 4).
After SDS-PAGE, proteins were blotted on a nitrocellulose filter, which
was then incubated with a mixture of anti-O2 and anti-Mybleu anti-
sera. Molecular mass markers are indicated in kDa.
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was also centrifuged. Each fraction of the marker gradient was
analyzed by SDS-PAGE, and the gel was stained with Coomas-
sie Brilliant Blue R-250 (Fig. 3, panel A). Each fraction of the
nuclear extract gradients was analyzed by Western blot using
a mixture of anti-Mybleu and anti-O2 antisera as primary
antiserum. In the single transformants, the position of both O2
and Mybleu along the gradient matched the one expected for
the respective homodimers (Fig. 3 panel B, fractions 2 and 3,
and panel C, fractions 6–8). In the double transformant, both
proteins migrated in the position expected for heterodimers
(Fig. 3, panel D, fractions 4 and 5). The identity of the two
bands was confirmed assaying an aliquot of fraction 5 of the
double transformant gradient by Western blot, using anti-My-
bleu, anti-O2, or both primary antisera (data not shown). These
results demonstrate that Mybleu and O2 form heterodimers
and that heterodimer formation is dominant over O2zO2 ho-
modimer assembly.
Gel Shift Assay with Transformed Tobacco Extracts—To an-
alyze directly the DNA binding properties of O2 and Mybleu,
we assayed the ability of homo- and heterodimers to bind the
O2 binding sites by gel shift experiments (Fig. 4). We used 10
mg of nuclear extract from protoplasts transformed with pCaM-
VMybleu (lanes 2), pCaMVO2 (lanes 3), or both constructs
(lanes 4) and, as a control, the nuclear extract of mock trans-
formed protoplasts (lanes 1). Under the salt conditions de-
scribed for O2-DNA binding (41), we were able to detect O2-
mediated probe retardation using the oligonucleotides
corresponding to the O2 binding site present in the zein pro-
moter (oligonucleotides O2 and O2B, containing respectively
one and two O2 binding sites (Ref. 38); Fig. 4, panels A and B,
lanes 3). The results obtained using several oligonucleotides
under different salt conditions are shown in panels B, C, and D
(40, 70, and 100 mM, respectively). Increasing the KCl concen-
tration, we could also detect probe retardation using oligonu-
cleotide 2,3 B32 (20) (panels C and D, lanes 3). Oligonucleotide
5 B32 is retarded only under very high salt concentration
(panel D, lane 3). We were not able to detect a retarded complex
using the 3 B32 oligonucleotide.
The fact that the extract from O2-expressing protoplasts, but
not the one from protoplasts expressing both O2 and Mybleu,
produced a retarded complex is consistent with the fact that
O2-homodimers are not detectable in cotransformed cells (Figs.
2 and 3).
Mybleu Is a Nuclear Protein—In Mybleu there is no canoni-
cal nuclear localization sequence. To determine whether the
transactivation activity of Mybleu in the presence of O2 results
from O2-mediated nuclear localization of Mybleu, we per-
formed immunolocalization experiments and Western blots on
nuclear and cytoplasmic extracts. Fig. 5 shows protoplasts
transformed with pCaMVMybleu (MYBLEU column), pCaMV-
O2 (O2 column), and both (O2/MYBLEU column) (10 mg/each).
Immunocytochemical localization (odd rows) was performed
using antiserum against either O2 or Mybleu, as primary an-
tibodies; as controls, antisera against the cytoplasmic protein
actin and preimmune serum were used. Nuclei were evidenced
by DAPI staining (even rows).
Immunocytochemical localization, performed on protoplasts
transformed with individual constructs, indicated that Mybleu
is able to enter the nucleus in the absence of O2. A similar
result was obtained by Western blot analysis of nuclear and
FIG. 3. Mybleu and O2 heterodimer formation. Molecular mark-
ers (panel A) and nuclear extracts from tobacco protoplasts transformed
with plasmids expressing Mybleu (panel B), O2 (panel C), or both (panel
D) were loaded onto a preformed sucrose sedimentation velocity gradi-
ent. Each fraction (lanes 1–15), after SDS-PAGE, was analyzed by
Coomassie Brilliant Blue R-250 staining (panel A) or by Western blot
using a mixture of anti-Mybleu and anti-O2 antisera as primary anti-
serum. Lanes 16, gradient pellet; lanes 17, nuclear extracts of trans-
formed protoplasts before gradient sedimentation. Molecular mass
markers are indicated in kDa. Markers: a, cytochrome c (12 kDa); b,
ovalbumin (43 kDa); c, bovine serum albumin (67 kDa); d, aldolase
(142-kDa trimer); e, catalase (232-kDa tetramer).
FIG. 4. Gel mobility shifts using nuclear extracts from trans-
formed tobacco protoplasts. Extracts from protoplasts untrans-
formed (lanes 1) and transformed with pCaMVMybleu (lanes 2),
pCaMVO2 (lanes 3), and both (lanes 4) were tested in gel mobility shift
assay. The oligonucleotides used are indicated at the top. Panel A,
binding reaction with oligonucleotide O2 under 40 mM KCl. Panels B, C,
and D, 40, 70 and 100 mM KCl, respectively.
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cytoplasmic extracts of protoplasts transformed with plasmids
expressing O2, Mybleu, or both (data not shown).
Mybleu Is Present in Rice—We aimed to verify whether un-
spliced myb7 mRNA, encoding Mybleu, was translated in rice.
In fact, the existence of Mybleu in rice would strongly suggest
a similar role in modulating activity of a natural rice transcrip-
tion factor.
Rice coleoptiles grow under both aerobic and anaerobic con-
ditions, whereas roots are unable to grow under anoxia. Be-
cause the level of the unspliced myb7 mRNA (putatively encod-
ing Mybleu) is decreased in anaerobically treated roots (7), we
hypothesized that Mybleu could be involved in the process of
cellular division. Immunoassay experiments on rice root and
coleoptile prints (Fig. 6A) showed signals in regions corre-
sponding to the dividing or undifferentiated cells, but not in the
completely expanded cells of the same organs, supporting the
above mentioned hypothesis. To confirm the presence of My-
bleu and its nuclear localization, we therefore immunoprecipi-
tated nuclear and cytoplasmic proteins extracted from meris-
tem-enriched segments of both roots and coleoptiles. Western
blot analysis of the nuclear proteins immunoprecipitated using
Mybleu antiserum shows the presence of a single band with a
molecular mass of 11 kDa, corresponding to the one expected
for Mybleu (Fig. 6B, lanes 11 and 13). In cytoplasmic extracts,
FIG. 5. Immunocytochemical localization of Mybleu and O2.
Tobacco protoplasts were transformed with pCaMVMybleu (MYBLEU),
pCaMV-O2 (O2) or both (O2/MYBLEU) and treated with different an-
tisera, as described in “Immunocytochemical Analysis” under “Experi-
mental Procedures.” Primary antisera used were anti-Mybleu (MY-
BLEU), anti-O2 (O2), anti-actin (ACTIN), and preimmune serum. Odd
rows show immunodetections; even rows show the same protoplasts
stained with DAPI, to locate nuclei.
FIG. 6. Mybleu is present in rice. Panel A, tissue print immunolo-
calization. Rice roots and coleoptiles were spread on nitrocellulose fil-
ters and assayed with Mybleu, actin, and preimmune antisera. Upper
row, rice tissues; lower row, immunodetection. Panel B, Western blot
analysis using anti-Mybleu antiserum. Periplasmic extracts of E. coli
(lanes 1–3), periplasmic (lanes 4–6), and cytoplasmic (lanes 7–9) ex-
tracts of E. coli expressing the maltose-binding protein-Mybleu fusion
protein are shown. Lanes 1, 4, and 7, uninduced cells; lanes 2, 5, and 8,
4 h of isopropyl-b-D-thiogalactopyranoside induction; lanes 3, 6, and 9,
6 h of isopropyl-b-D-thiogalactopyranoside induction. Coleoptile subcel-
lular fractions immunoprecipitated with anti-Mybleu antiserum are
shown in lane 10 (cytoplasmic) and lane 11 (nuclear). Root subcellular
fractions immunoprecipitated with anti-Mybleu antiserum are indi-
cated in lane 12 (cytoplasmic) and lane 13 (nuclear). Molecular mass
markers are indicated.
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the antiserum did not react with any protein (lanes 10 and 12).
Western blot analysis of periplasmic extracts from E. coli ex-
pressing or not the Maltose binding protein-Mybleu fusion
protein (used to produce the anti-Mybleu antiserum) was per-
formed (lanes 1–6). The presence of a single band of expected
molecular mass (44 kDa) in lanes 5 and 6 demonstrated the
specificity of the anti-Mybleu antiserum. We did not detect any
protein reacting with preimmune serum (data not shown). We
conclude that Mybleu is synthesized in apexes of rice roots and
coleoptiles.
Finally, we were also able to detect Mybleu in nuclei of
established suspension cultures of rice (data not shown).
DISCUSSION
The high amount of unspliced myb7 mRNA with respect to
the spliced form, the increase of the spliced form in roots during
anoxia, and the presence of a leucine zipper in the polypeptide
encoded by the unspliced mRNA suggest a regulatory role for
myb7 splicing (7).
We showed here that Mybleu is expressed in vivo in both root
and coleoptile meristematic regions and in established cell
cultures. The results of transient expression in tobacco proto-
plasts indicate that Mybleu enhances the activity of the bZIP
O2. These results support the hypothesis mentioned above and
suggest an in vivo function as transcriptional activator.
Mybleu activity is synergistic rather than additive with re-
spect to that of O2; in fact, Mybleu alone has no effect on b32
promoter transactivation. Equal amounts of O2- or of a mixture
of O2- and Mybleu- encoding plasmids have similar activities
(in activating the b32 promoter). When coexpressed, the two
proteins form mainly, if not exclusively, heterodimers. This
was demonstrated by the absence of O2 remaining in the su-
pernatant after immunoprecipitation with anti-Mybleu anti-
serum and vice versa and by the sedimentation velocity exper-
iment on the extract from cotransformed tobacco protoplasts.
In fact, when coexpressed, both proteins are present in frac-
tions expected to contain heterodimers and are no longer de-
tectable in the fractions corresponding to the respective ho-
modimers. These results demonstrate that the heterodimer is
as active as the O2 homodimer in activating transcription. The
disappearance of the O2 homodimers in the presence of Mybleu
is also consistent with the results of the gel shift experiments;
the presence of Mybleu abolishes the specific shift driven by
O2. Our failure to detect a shift driven by the heterodimer may
be due to a different affinity of the heterodimer with respect to
the homodimer. Further factors and/or conditions acting in vivo
might influence the binding affinity and stability and therefore
the transcriptional activity.
Intron splicing is in general an accurate and efficient proc-
ess, and relevant amounts of unspliced transcripts are detected
only in cells subjected to severe stress (14, 48–50). However,
some mRNAs encoding transcription factors are subjected to
regulated splicing. This can produce mRNAs encoding different
transcription factors with distinct functions (51–55). Natural
and artificially incomplete transcription factors (lacking the
activation domain) are able to interact with complete factors
and act as negative dominants (44–47, 56).
However, Mybleu is not a repressor, but is a synergistic
effector on O2 activity. An example of the in vivo presence of
incomplete transcription factors, able to activate transcription
only by interacting with the proper partner, is the Maf family
of mammals (57). The Maf protein contains a basic DNA bind-
ing domain followed by an extended leucine zipper, but it lacks
a recognizable activator domain. Both Maf homo- and het-
erodimers (with two members of the NFE2/CNC-bZIP family)
are able to bind the NFE2 site present in the promoter region
of g-globin. Nevertheless, they exert opposite effects: het-
erodimers stimulate whereas homodimers inhibit the expres-
sion driven by the g-globin promoter (57). Mybleu has no re-
pressor activity as a homodimer, probably because it lacks a
DNA binding domain. Our results recall the cooperative acti-
vation of muscle gene expression, driven by Mef2 and myogenic
bHLH proteins (58). Mef2 and its HLH partner are produced in
vivo as complete transcription factors and may activate pro-
moters that contain either one, the other, or both of the regions
recognized by each of them. Using deletion mutations, Molk-
entin et al. (58) demonstrated that this cooperation requires
direct interactions and that only one factor containing a trans-
activation and a DNA binding domain is needed in the
heterodimers.
We have shown here that Mybleu is a natural factor that has
a positive transcriptional effect, although it seems to lack both
a DNA binding and a transactivation domain. It might be a
general synergistic effector of several leucine zipper factors, by
changing their conformation and/or allowing the interaction
with other proteins. Although the effect of Mybleu is not dra-
matic, it is clear that the heterodimer is able to activate tran-
scription. We may hypothesize that Mybleu in vivo is able to
dimerize with nuclear factor(s) that are unable to form ho-
modimers or that the DNA binding properties of the het-
erodimers are different in some way from that of the ho-
modimers, as suggested by gel shift experiments and as already
demonstrated for other transcriptional factors (59–61). If this
is the case, the differential comparative effect on different
promoters of the heterodimers with respect to homodimers
could have a relevant biological significance. Further work is in
progress to clarify if such a mechanism is present. It should
also be noted that the same RNA encodes two active transcrip-
tion factors, belonging to different classes depending on the
splicing. Finally, Mybleu represents a new class of transcrip-
tion factors, characterized by the presence of a leucine zipper
following an incomplete Myb domain. Further investigations
are necessary to identify its natural partner in rice.
Although we were unable to identify any nuclear localization
sequence along the Mybleu amino acid sequence, immunocyto-
chemical and Western blot assays demonstrated its nuclear
location both in rice and in transformed tobacco protoplasts.
Several nuclear proteins, and among them some Myb factors,
do not show any canonical consensus for nuclear localization
(62–64). Some of these enter the nuclei only upon interaction
with their partner, like APETALA and PISTILLATA (65), and
Dp and E2F (66). If Mybleu enters the nucleus upon interaction
with a partner, this should be a widespread or an unspecific
factor, present also in tobacco protoplasts.
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